BTAL

AGF U.S. Market Neutral Anti-Beta Fund

Fundamental data last updated:June 4, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Financial Services

industry

Asset Management

Exchange

AMEX

County of HQ

US

Next Earnings Date

Not Scheduled

Business Summary

The fund will invest primarily in long positions in low beta U.S. equities and short positions in high beta U.S. equities on a dollar neutral basis, within sectors. It will construct a dollar neutral portfolio of long and short positions of U.S. equities by investing primarily in the constituent securities of the Dow Jones U.S. Thematic Market Neutral Low Beta Index in approximately the same weight as they appear in the index. The universe for the index is comprised of the top 1,000 eligible securities by market capitalization, including REITs.

 


VALUATION

P/E

N/A

Market Cap ($M USD)

$379.88M

Forward P/E

N/A

PEG

N/A

PRICE TO SALES

N/A

PRICE TO BOOK

N/A

EV / EBITDA

N/A

5-Year Average P/E

Free Cash Flow Yield

N/A

DCF Value

N/A

Graham Number

N/A

Price to FCF

N/A

EV to FCF

N/A

Earnings Yield

N/A

FCF Yield

N/A

DIVIDEND

Yield

N/A

Annual Payout

N/A

Payout Ratio

N/A

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

N/A

Next Year EPS Growth Estimate

N/A

Next Year Revenue Growth Estimate

N/A

Return on Equity (ROE)

N/A

FREE CASH FLOW

Operating Margin

N/A

Debt-to-Equity

N/A

Piotroski F-Score

N/A

Altman Z-Score

N/A

Return on Invested Capital (ROIC)

N/A

Current Ratio

N/A

Quick Ratio

N/A

Net Debt to EBITDA

N/A

Interest Coverage

N/A

Gross Profit margin

N/A

FCF PER SHARE

N/A

REVENUE PER SHARE

N/A

Gainseekers Quantitative Analysis

Summary

The market seems to be flying blind with BTAL, as key valuation metrics like DCF Value and Graham Number are missing, leaving investors without a clear anchor. The absence of a Forward P/E and Earnings Yield further clouds the picture, making it difficult to assess growth potential or safety. With no Altman Z-score, the financial health remains an enigma. The stock’s significant distance from its 52-week high suggests a lack of investor confidence, possibly due to these valuation uncertainties. Overall, BTAL’s financial opacity makes it a challenging proposition for value investors.

AI Exposure / Tech Reliance

In the asset management industry, BTAL is positioned to leverage AI for enhanced portfolio management and risk assessment. While the sector is ripe for tech-driven efficiencies, BTAL's specific adaptability remains unclear due to the lack of detailed financial metrics. However, its negative beta indicates potential resilience in volatile markets, possibly benefiting from algorithmic strategies.

The Bull Case

A GARP investor might find BTAL intriguing due to its potential resilience in turbulent markets, as indicated by its negative beta. However, the lack of data on ROIC, FCF Yield, and Piotroski F-Score leaves much to be desired in terms of assessing capital efficiency or pricing power. Without these insights, the bull case is more speculative than grounded, relying on the hope of untapped institutional tailwinds.

The Bear Case

BTAL's most glaring weakness is its technical overextension, trading well below its 50-Day and 200-Day SMAs. The absence of critical financial metrics like Price/Book and Price/Sales ratios leaves investors in the dark about its valuation. This opacity, combined with the lack of earnings and cash flow data, makes it a risky bet. The stock's proximity to its 52-week low further underscores potential structural vulnerabilities.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

N/A

Average Analyst Price Target

N/A

Institutional Ownership %

1-Year Beta

-0.88

Insider Buying % (6 Mo)

Distance to 52-Week High

67.09%

Distance to 52-Week Low

0.65%

EARNINGS SURPRISE %

N/A

50-DAY SMA

$12.85

200-DAY SMA

$14.43

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.